67 related articles for article (PubMed ID: 1578946)
41. Quality of life in adult patients with acute myeloid leukemia receiving intensive and prolonged chemotherapy -- a longitudinal study.
Schumacher A; Kessler T; Büchner T; Wewers D; van de Loo J
Leukemia; 1998 Apr; 12(4):586-92. PubMed ID: 9557618
[TBL] [Abstract][Full Text] [Related]
42. Treatment strategies in acute myeloid leukemia (AML). A. First-line chemotherapy.
Buechner T; Hiddemann W
Blut; 1990 Feb; 60(2):61-7. PubMed ID: 2405924
[TBL] [Abstract][Full Text] [Related]
43. Maintenance for acute myeloid leukemia revisited.
Büchner T; Krug U; Berdel WE; Heinecke A; Sauerland MC; Wörmann B; Hiddemann W
Curr Treat Options Oncol; 2007 Aug; 8(4):296-304. PubMed ID: 18058075
[TBL] [Abstract][Full Text] [Related]
44. Maintenance Therapy in AML.
Reville PK; Kadia TM
Front Oncol; 2020; 10():619085. PubMed ID: 33604298
[TBL] [Abstract][Full Text] [Related]
45. Maintenance therapy in acute myeloid leukemia: an evidence-based review of randomized trials.
Rashidi A; Walter RB; Tallman MS; Appelbaum FR; DiPersio JF
Blood; 2016 Aug; 128(6):763-73. PubMed ID: 27354720
[No Abstract] [Full Text] [Related]
46. Optimal therapy for adult patients with acute myeloid leukemia in first complete remission.
Wiernik PH
Curr Treat Options Oncol; 2014 Jun; 15(2):171-86. PubMed ID: 24792016
[TBL] [Abstract][Full Text] [Related]
47. Treatment of older patients with AML.
Büchner T; Berdel WE; Wörmann B; Schoch C; Haferlach T; Schnittger S; Kern W; Aul C; Lengfelder E; Schumacher A; Reichle A; Staib P; Balleisen L; Eimermacher H; Grüneisen A; Rasche H; Sauerland MC; Heinecke A; Mesters RM; Serve HL; Kienast J; Hiddemann W
Crit Rev Oncol Hematol; 2005 Nov; 56(2):247-59. PubMed ID: 16246568
[TBL] [Abstract][Full Text] [Related]
48. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
[TBL] [Abstract][Full Text] [Related]
49. Oral induction and consolidation of acute myeloid leukemia with etoposide, 6-thioguanine, and idarubicin (ETI) in elderly patients: a randomized comparison with 5-day TAD. Finnish Leukemia Group.
Ruutu T; Almqvist A; Hallman H; Honkanen T; Järvenpää E; Järventie G; Koistinen P; Koivunen E; Lahtinen R; Lehtinen M
Leukemia; 1994 Jan; 8(1):11-5. PubMed ID: 8289475
[TBL] [Abstract][Full Text] [Related]
50. Combined effect of very early intensification and prolonged post-remission chemotherapy in patients with AML.
Büchner T; Hiddemann W; Schaefer UW; Löffler H; Maschmeyer G; Ludwig WD; Aul C; Lathan B; Heinecke A
Leukemia; 1992 Nov; 6 Suppl 4():68-70. PubMed ID: 1434838
[TBL] [Abstract][Full Text] [Related]
51. Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG).
Ohno R; Kobayashi T; Morishima Y; Hiraoka A; Imai K; Asoh N; Tsubaki K; Tomonaga M; Takahashi I; Kodera K
Leukemia; 1992; 6 Suppl 2():92-5. PubMed ID: 1578954
[TBL] [Abstract][Full Text] [Related]
52. Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia.
Novitzky N; Thomas V; Abrahams L; du Toit C; McDonald A
Am J Hematol; 2004 Aug; 76(4):319-29. PubMed ID: 15282663
[TBL] [Abstract][Full Text] [Related]
53. Longterm effects of prolonged maintenance and of very early intensification chemotherapy in AML: data from AMLCG.
Büchner T; Hiddemann W; Wörmann B; Löffler H; Maschmeyer G; Hossfeld D; Ludwig WD; Nowrousian M; Aul C; Schaefer UW
Leukemia; 1992; 6 Suppl 2():68-71. PubMed ID: 1578946
[TBL] [Abstract][Full Text] [Related]
54. Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML Cooperative Group.
Büchner T; Hiddemann W; Löffler G; Gassmann W; Maschmeyer G; Heit W; Hossfeld D; Weh H; Ludwig WD; Thiel E
Semin Hematol; 1991 Jul; 28(3 Suppl 4):76-9. PubMed ID: 1780757
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
